1. In Vivo Evaluation of Muscle Specific Synthetic Promoters

    Lu-Nguyen, N.

    SynPromics Ltd: £266,984

    2/01/19 → …

    Project: Research

  2. Development of CRISPR/Cas Genome Editing as a Treatment for Ataxia Telangiectasia

    Yáñez-Muñoz, R. J.

    Action for AT: £200,000, Action for AT: £40,000

    1/11/1730/06/21

    Project: Research

  3. ABI innovation: A Graph based Approach for the Genome Wide Prediction of Conditionally Essential Genes

    Paccanaro, A.

    National Science Foundation (NSF): £13,078, National Science Foundation: £13,169, National Science Foundation (NSF): £13,664

    15/09/1714/09/20

    Project: Research

  4. In vivo evaluation of muscle specific synthetic promoters

    Dickson, G.

    SynPromics Ltd: £67,992, SynPromics Ltd: £55,436

    1/08/1730/04/18

    Project: Research

  5. Genome Editing in Muscle Stem Cells for Duchenne Muscular Dystrophy

    Dickson, G.

    Rosetrees Trust: £20,000

    1/02/1731/01/18

    Project: Other

  6. Development of cell-penetrating peptide-conjugated antisense oligonucleotides for the treatment of Fascioscapulohumeral Muscular Dystrophy

    Lu-Nguyen, N.

    Muscular Dystrophy UK: £71,342, Muscular Dystrophy UK: £71,303, Muscular Dystrophy UK: £72,333

    1/10/1631/10/18

    Project: Research

  7. In vivo activity assessment of four AAV OPMD clinical constructs – PhasesI&II

    Dickson, G.

    Benitec Ltd: £186,700, Benitec Ltd: £116,000, Benitec Ltd: £13,998

    1/09/1631/07/17

    Project: Other

  8. Prediction of drug cocktails with anti-trypanosomal effect

    Paccanaro, A.

    Eng & Phys Sci Res Council EPSRC: £8,976

    1/06/1631/03/17

    Project: Research

  9. The UK Spinal Muscular Atrophy Research Consortium

    Yáñez-Muñoz, R. J.

    The SMA Trust: £215,053

    1/01/163/03/20

    Project: Research

  10. Inducing Immune-Tolerance to AAV Vector Capsid for Gene Therapy of Duchenne Muscular Dystrophy

    Dickson, G.

    Jesse's Journey: £102,041, Jesse's Journey: £59,172, Jesse's Journey: £112,979

    1/10/1531/08/20

    Project: Research

  11. Second generation hyper-active micro-dystrophin AAV vectors for Duchenne muscular dystrophy gene therapy

    Dickson, G.

    Muscular Dystrophy Campaign: £59,965, Muscular Dystrophy Campaign: £57,679, Muscular Dystrophy Campaign: £56,456

    1/10/1530/09/18

    Project: Research

  12. Stage 2 study on DNA-directed RNAi for the treatment of OPMd

    Dickson, G.

    Benitec Ltd: £408,200, Benitec Ltd: £19,981

    1/09/1531/08/16

    Project: Research

  13. Towards a clinical trial for Oculopharyngeal Muscular Dystrophy

    Lu-Nguyen, N.

    Association Francais contre les Myopathies: £202,546

    1/07/1430/06/19

    Project: Research

  14. Towards a clinical trial for Oculopharyngeal Muscular Dystrophy (OPMD)

    Dickson, G.

    Association Francais contre les Myopathies: £29,811

    1/07/1430/06/19

    Project: Research

  15. Correction of Duchenne Muscular Dystrophy Mutations using Endonuclease-Mediated Genome Surgery

    Dickson, G.

    Muscular Dystrophy Campaign: £26,568, Muscular Dystrophy Campaign: £26,568

    1/10/1330/09/14

    Project: Research

  16. Development of dual/triple transpliced AAV vectors to restore quasi/full length dystrophin variants to muscle

    Dickson, G.

    Muscular Dystrophy Campaign: £58,425, Muscular Dystrophy Campaign: £60,087, Muscular Dystrophy Campaign: £60,087, Muscular Dystrophy Campaign: £61,794

    1/10/1330/09/16

    Project: Research

  17. Vectorisation of Chondroitinase for therapy in spinal cord injury

    Yáñez-Muñoz, R. J.

    International Spinal Research Trust: £50,043, International Spinal Research Trust: £25,100, International Spinal Research Trust: £25,100

    1/10/1330/09/15

    Project: Research

  18. MAPK signalling network to adapt leaf growth to drought conditions

    Bogre, L., Paccanaro, A. & Papdi, C.

    European Commission: £177,130

    1/05/1330/04/15

    Project: Research

  19. Gene Surgery for Duchenne Muscular Dystrophy(DMD)

    Dickson, G. & Yáñez-Muñoz, R. J.

    Association Francais contre les Myopathies: £224,060

    1/04/1331/03/15

    Project: Research

  20. Inference of RBR network and dynamic RBR complexes during leaf development

    Paccanaro, A., Bogre, L. & Horvath, B.

    European Commission: £255,440

    1/03/1328/02/15

    Project: Research

  21. Combination Antisense Treatment for Duchenne Muscular Dystrophy: Open Reading Frame Rescue of Dystrophin in conjunction with Destructive Exon Skipping of Myostatin mRNA

    Lu-Nguyen, N.

    Muscular Dystrophy Campaign: £40,675, Muscular Dystrophy Campaign: £41,556, Muscular Dystrophy Campaign: £42,465

    1/02/1231/08/15

    Project: Research

  22. Pathophysiology and therapeutic approaches in Oculoparyngeal Muscular Dystropy (OPMD)

    Dickson, G.

    Association Francais contre les Myopathies: £120,523

    1/05/1130/04/13

    Project: Research

  23. Advances in oligonucleotide-mediated exon skipping for DMD and related disorders

    Dickson, G.

    Association Francais contre les Myopathies: £105,626

    1/04/1131/03/15

    Project: Research

  24. UK HVC

    Dickson, G.

    Wellcome Trust: £132,000, Wellcome Trust: £20,000, Wellcome Trust: £50,000

    1/02/1131/01/13

    Project: Research

  25. Meganuclease-Enhance Genome Correction Therapy for Duchenne Muscular Dystrophy

    Dickson, G.

    Association Francais contre les Myopathies: £35,514, Association Francais contre les Myopathies: £30,508, Association Francais contre les Myopathies: £36,741, Association Francais contre les Myopathies: £15,260, Association Francais contre les Myopathies: £11,647

    1/04/1031/03/12

    Project: Research